Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine.
about
Intravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulation.Low Serum Lysosomal Acid Lipase Activity Correlates with Advanced Liver DiseaseTransfusion management and immunohematologic complications in liver transplantation: experience of a single institution.The Role of Ischemia Modified Albumin as a Biomarker in Patients with Chronic Liver Disease.Serum cholinesterase: A predictive biomarker of hepatic reserves in chronic hepatitis D
P2860
Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical applications of the M ...... se (MELD) in hepatic medicine.
@en
Clinical applications of the Model for End-Stage Liver Disease
@nl
type
label
Clinical applications of the M ...... se (MELD) in hepatic medicine.
@en
Clinical applications of the Model for End-Stage Liver Disease
@nl
prefLabel
Clinical applications of the M ...... se (MELD) in hepatic medicine.
@en
Clinical applications of the Model for End-Stage Liver Disease
@nl
P2860
P356
P1476
Clinical applications of the M ...... se (MELD) in hepatic medicine.
@en
P2093
Jawad Ahmad
P2860
P356
10.2147/HMER.S9049
P577
2013-02-11T00:00:00Z